Updated recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

The interim recommendations  for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to
reflect latest evidence.

For further information, see below: